Techno Trends

TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

New Anti-Malaria Agents to Block Malaria Transmission

Merck and the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, have confirmed their findings of a novel class of candidate antimalarial agents that blocks the multiple stages of the malaria parasite’s lifecycle that causes the disease....

Trinity Researchers Discovered a New Breakthrough for Asthma Patients

A new breakthrough has been discovered by the researchers from Trinity College Dublin, for people living with asthmathat may eventually lead to improved therapeutic options. An important role in defending against bacteria is played by Caspase-11. However, it has never been implicated in this disease before....

Sticky Cancer Cells Could Improve Cancer Prognosis

A microfluidic device has been created by a team of researchers led by the University of California San Diego which measures how ‘sticky’ cancer cells are and how they could improve prognostic evaluation of patient tumors....

Resverlogix Launches New Drug for MACE Prevention

A new drug, apabetalone in combination with the top standard of care, including high-intensity statins, has been launched by Resverlogix. The treatment was intended for the secondary prevention of Major Adverse Cardiac Events (MACE) in patients with type 2 diabetes mellitus and recent acute coronary syndrome....

Novel Anti-Alcoholism Drug Developed to Treat Cancer

A team of researchers from the Tokyo University of Science and other institutes have developed a first-of-its-kind cancer treatment strategy that targets a pro-tumor protein ‘FROUNT’ and suppresses Tumor-Associated Macrophages (TAMs)....

Aprea Therapeutics to Treat Myelodysplastic Syndromes

Aprea Therapeutics has launched a mutant p53 reactivating compound APR-246 in combination with chemotherapy drug azacitidine for the treatment of Myelodysplastic Syndromes (MDS) in patients having a susceptible TP53 mutation....

Novel Potential Target Discovered for Drug Addiction Treatment

A new potential target for treating drug addiction through astrocytes, which the researchers from the University of Minnesota Medical School refer to ‘the hidden stars of the brain’, has been discovered....

Personalized Cancer Monitoring Technology Launched to Treat Cancer Patients

A Personalized Cancer Monitoring (PCM) technology designed for minimally invasive monitoring and recurrence surveillance for early-stage cancer has been launched by ArcherDX....

New Breakthrough Anticancer Drug Discovered

A safer and more effective anticancer drug has been discovered by researchers from the University of Florida College of Pharmacy. The new treatment would target leukemia, lymphoma, and breast and lung cancers....

The University of Cincinnati Researchers Develop New Treatment for Brain Cancer

A new treatment and an industrial fabrication process called coaxial electrospinning have been developed by the researchers at the University of Cincinnati for the treatment of glioblastoma multiforme or GBM....

University of California Researchers Invent New Technology to Cure Cancer

The researchers at the University of California, Riverside in collaboration with researchers at City of Hope National Medical Center have invented deterministic mechanoporation or DMP - a novel microfluidic device technology to treat cancer....

University of Liverpool Researchers Discover New Technique in Cell Signaling

The researchers at the University of Liverpool have made a new discovery in the field of cell signaling. Generally, the signaling in cell regulates cell growth and repair in humans. However, abnormal cell signaling can lead to many diseases, including cancer and neurodegeneration....

University Of California Researchers Develop New Enzyme Linked to Cell Growth, Cancer

The researchers from the University of California have discovered the structure of ZCCHC4, a novel RNA-modifying enzyme. The cell proliferation is influenced by ZCCHC4 and has been linked to cancers. Apart from this, they also identified the mechanism that controls how the ZCCHC4 enzyme recognises its substrate....

The University of Bath Researchers Develop New Saliva Test to Detect Synthetic Drug

A simple saliva test has been developed by the researchers at the University of Bath to detect if someone has recently taken the street drug ‘spice’. The substance known as ‘spice’, is usually a mixture of dried and shredded plant material, sprayed with various synthetic chemicals meant to mimic the main component of cannabis....

Mirum Pharmaceuticals Launch New Drug for Treatment of Alagille Syndrome

Mirum Pharmaceuticals has launched a novel drug Maralixibat, for the treatment of pruritus associated with Alagille syndrome (ALGS) in patients one year of age and older. ALGS is a rare genetic disorder within which digestive juice ducts are abnormally slim, unshapely and reduced in a range that ends up in digestive juice within the liver and ultimately progressive disease....

Eli Lilly Launch New Drug to Treat Acute Migraine in Adults

A new oral medication, REYVOW™ (lasmiditan) has been launched by Eli Lilly and Company for the treatment of acute migraine, with or without aura, in adults. The drug, REYVOW is delivered orally via a tablet and is the first serotonin receptor agonist. It binds to (5-HT) 1F receptor with high affinity....

New Oral Inhibitor Launched to Treat Patients with Histiocytic Neoplasms

A new oral inhibitor, cobimetinib (Cotellic) has been launched by the Memorial Sloan Kettering Cancer Center (MSK) for the treatment of adult patients with histolytic neoplasms (HN) (Erdheim-Chester Disease, Rosai-Dorfman, Langerhans Histiocytosis)....

Janssen Pharma’s Niraparib Treats Patients with Prostate Cancer

A new orally-administered poly ADP-ribose polymerase (PARP) inhibitor, Niraparib has been launched by the Janssen Pharmaceutical Companies of Johnson & Johnson....

UC Santa Cruz Researchers Develop Novel Nanoprobes

A new ultrasensitive nanoscale optical probe has been developed by the researchers at UC Santa Cruz that can monitor the bioelectric activity of neurons and other excitable cells....

Boehringer Ingelheim Launches Breakthrough Medication for Treatment of ILDs

A new medication, Ofev® (nintedanib) has been launched by Boehringer Ingelheim for the treatment of patients with chronic fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype....

MECO - 90 Years